FDA Grand Rounds
Highlights monthly webcast presentations for CE credit by FDA scientists from across agency on their cutting-edge scientific research
Highlights monthly webcast presentations for CE credit by FDA scientists from across agency on their cutting-edge scientific research
Sam Chang engages with Josh Meeks to discuss nadofaragene firadenovec’s role in treating BCG-unresponsive bladder cancer. They consider the significance of clinical trials and FDA…
Assisting Healthcare Providers with Expanded Access Requests for Investigational Oncology Products
AUA 2024, metatatic renal cell carcinoma (mRCC), Sarcomatoid Features in mRCC, metastatic sarcomatoid renal cell carcinoma (msRCC), Cytoreductive Nephrectomy, Immune Checkpoint Inhibitors (ICI), ipilimumab, nivolumab,…
AUA 2024 telemedicine in urology, use of telehealth could reduce racial and ethnic disparities in prostate cancer care, National Health Interview Survey, prostate cancer.
AUA 2024 non-invasive bladder cancer, phase 1 study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11, non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).
AUA 2024 prostate cancer detection and screening, results of a comparative analysis of clinician performance versus magnetic resonance imaging (MRI), ultrasound integration for artificial intelligence-based…
A controversial provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare Part D nearly $15 billion from
AUA 2024 prostate cancer detection and screening, characteristics of PIRADS 5 lesions in men with a negative or Grade Group 1 biopsy, Prostate Imaging Reporting…
AUA 2024 prostate cancer detection and screening, midlife baseline PSA as a predictor of lethal prostate cancer between Black and White men, prostate cancer mortality.
AUA 2024, prostate cancer, Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography (PSMA-PET), radical prostatectomy (RP), Biochemical Recurrent prostate cancer, 68Ga-PSMA PET/CT, Biochemical Recurrence Following Prostatectomy,…